Milena Gulinac

Dr. Milena Gulinac


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in World Journal of Clinical Cases
Verified
Journal Article
Open access
MGMilena Gulinac
Milena Gulinac
DMDimitrina Georgieva Miteva
Dimitrina Georgieva Miteva
MPMonika Peshevska-Sekulovska
Monika Peshevska-Sekulovska
INIvan P Novakov
Ivan P Novakov
SASvetozar Antovic
Svetozar Antovic
TVTsvetelina Velikova
Tsvetelina Velikova
Dietary imbalance and overeating can lead to an increasingly widespread disease - obesity. Aesthetic considerations aside, obesity is defined as an excess of adipose tissue that can lead to serious health problems and can predispose to a number of pathological changes and clinical diseases, including diabetes; hypertension; atherosclerosis; coronary artery disease and stroke; obstructive sleep apnea; depression; weight-related arthropathies and endometrial and breast cancer. A body weight 20% above ideal for age, gender and height is a severe health risk. Bariatric surgery is a set of surgical methods to treat morbid obesity when other treatments such as diet, increased physical activity, behavioral changes and drugs have failed. The two most common procedures currently used are sleeve gastrectomy and gastric bypass. This procedure has gained popularity recently and is generally considered safe and effective. Although current data show that perioperative mortality is low and better control of comorbidities and short-term complications is achieved, more randomized trials are needed to evaluate the long-term outcomes of bariatric procedures. This review aims to synthesize and summarize the growing evidence on the long-term effectiveness, outcomes and complications of bariatric surgery.

18 June 2023 in World Journal of Transplantation
Verified
Journal Article
Open access
PKPlamena Kabakchieva
Plamena Kabakchieva
YAYavor Assyov
Yavor Assyov
Stavros GerasoudisStavros Gerasoudis
Stavros Gerasoudis
GVGeorgi Vasilev Vasilev
Georgi Vasilev Vasilev
Monika Peshevska-SekulovskaMonika Peshevska-Sekulovska
Monika Peshevska-Sekulovska
Tsvetelina VelikovaTsvetelina Velikova
Tsvetelina Velikova
Islet transplantation-immunological challenges and current perspectives

2 August 2024 in Gastroenterology Insights
Verified
Journal Article
Open access
PDF file
Tsvetelina VelikovaTsvetelina Velikova
Tsvetelina Velikova
IKIssa El Kaouri
Issa El Kaouri
KBKonstantina Bakopoulou
Konstantina Bakopoulou
MGMilena Gulinac
Milena Gulinac
KNKremena Naydenova
Kremena Naydenova
Snezhina LazovaSnezhina Lazova
Snezhina Lazova
Mucosal immunity and trained innate immunity of the gut play a pivotal role in maintaining intestinal homeostasis and defending against microbial pathogens. This review provides an overview of the mechanisms underlying mucosal immunity and the concept of trained innate immunity in the gut. We discuss the interaction between gut microbiota and the host immune system, highlighting the role of epithelial cells, dendritic cells, and innate lymphoid cells, as well as the novel concept of trained innate immunity and its role in perpetuating or attenuating gut inflammation. We also comment on the current models for investigating mucosal immunity, their limitations, and how they can be overcome. Additionally, we explore the potential therapeutic implications of modulating mucosal immunity and trained innate immunity in gastrointestinal diseases. Only by elucidating the mechanisms underlying mucosal immunity and the concept of trained innate immunity, innovative approaches to modulate immune responses and restore intestinal homeostasis in the context of gastrointestinal disorders could be implemented.

30 June 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
Dimitrina Georgieva MitevaDimitrina Georgieva Miteva
Dimitrina Georgieva Miteva
Meglena KitanovaMeglena Kitanova
Meglena Kitanova
HBHristiana Batselova
Hristiana Batselova
Snezhina LazovaSnezhina Lazova
Snezhina Lazova
LCLyubomir Chervenkov
Lyubomir Chervenkov
Tsvetelina VelikovaTsvetelina Velikova
Tsvetelina Velikova
Although the chief of the World Health Organization (WHO) has declared the end of the coronavirus disease 2019 (COVID-19) as a global health emergency, the disease is still a global threat. To be able to manage such pandemics in the future, it is necessary to develop proper strategies and opportunities to protect human life. The data on the SARS-CoV-2 virus must be continuously analyzed, and the possibilities of mutation and the emergence of new, more infectious variants must be anticipated, as well as the options of using different preventive and therapeutic techniques. This is because the fast development of severe acute coronavirus 2 syndrome (SARS-CoV-2) variants of concern have posed a significant problem for COVID-19 pandemic control using the presently available vaccinations. This review summarizes data on the SARS-CoV-2 variants that are responsible for severe COVID-19 and the clinical efficacy of the most commonly used vaccines in clinical practice. The consequences after the disease (long COVID or post-COVID conditions) continue to be the subject of studies and research, and affect social and economic life worldwide.

17 October 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
MSMetodija Sekulovski
Metodija Sekulovski
NMNiya Mileva
Niya Mileva
GVGeorgi Vasilev Vasilev
Georgi Vasilev Vasilev
Dimitrina Georgieva MitevaDimitrina Georgieva Miteva
Dimitrina Georgieva Miteva
MGMilena Gulinac
Milena Gulinac
Tsvetelina VelikovaTsvetelina Velikova
Tsvetelina Velikova
Although abundant data confirm the efficacy and safety profile of the developed vaccines against COVID-19, there are still some concerns regarding vaccination in high-risk populations. This is especially valid for patients susceptible to thrombotic or bleeding events and hesitant people due to the fear of thrombotic incidents following vaccination. This narrative review focuses on various inherited and acquired thrombotic and coagulation disorders and the possible pathophysiologic mechanisms interacting with the coagulation system during immunization in view of the currently available safety data regarding COVID-19 vaccines. Inherited blood coagulation disorders and inherited thrombotic disorders in the light of COVID-19, as well as blood coagulation and thrombotic disorders and bleeding complications following COVID-19 vaccines, along with the possible pathogenesis hypotheses, therapeutic interventions, and imaging for diagnosing are discussed in detail. Lastly, the lack of causality between the bleeding and thrombotic events and COVID-19 vaccines is debated, but still emphasizes the importance of vaccination against COVID-19, outweighing the minimal risk of potential rare adverse events associated with coagulation.

6 December 2023 in Antibodies
Verified
Journal Article
Open access
PDF file
Monika Peshevska-SekulovskaMonika Peshevska-Sekulovska
Monika Peshevska-Sekulovska
MGMilena Gulinac
Milena Gulinac
RRRadoslav Rangelov
Radoslav Rangelov
DDDesislava Docheva
Desislava Docheva
Tsvetelina VelikovaTsvetelina Velikova
Tsvetelina Velikova
MSMetodija Sekulovski
Metodija Sekulovski
Celiac disease (CD) is an autoimmune condition that is initiated in genetically susceptible individuals by the exposure of the intestines to gluten, and the early start of symptoms is related to malabsorption. Atypical variants of the illness are often identified in adulthood and are frequently associated with manifestations outside of the intestines, including metabolic osteopathy, anemia, and dermatitis herpetiformis. But also, empirical data suggest a correlation between CD and reproductive abnormalities, including repeated abortions. Infertility and repeated miscarriages frequently manifest in women diagnosed with CD and may serve as the initial clinical indication of a subclinical form. Furthermore, the condition may manifest as amenorrhea, infertility, and the delivery of infants with a low birth weight. Regarding the mechanisms of CD in infertility, along with the anti-tTG action to hinder the invasiveness of trophoblast, these antibodies could damage endometrial angiogenesis, which has been shown in in vitro models with human endometrial cells and in vivo in murine models. Another important aspect is the role of nutrient deficiencies, such as zinc deficiency (connected to impaired hormone production, secondary amenorrhea, and pre-eclampsia) and folic acid, etc. Therefore, our objective was to conduct a comprehensive review of the existing literature pertaining to this specific topic and to elucidate the role of the autoantibodies in its pathogenesis.